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Secretion of proteins in Gram-negative bacteria is a high-energy-consuming process that requires translocation across twomem-
branes and a periplasmic space composed of a mesh-like layer, the peptidoglycan. To achieve this, bacteria have evolved complex
secretion systems that cross these barriers, and in many cases there are specific peptidoglycanases that degrade the peptidoglycan
to allow the proper assembly of the secretionmachinery. We describe here the identification and characterization of a murami-
dase in Brucella abortus that participates in the intracellular multiplication in professional and nonprofessional phagocytes. We
demonstrated that this protein has peptidoglycanase activity, that a strain with a clean deletion of the gene displayed a defect in
the early stages of the intracellular multiplication curve, and that this is dependent on the lytic activity. While neither the attach-
ment nor the invasion of the strain was affected, we demonstrated that it had a defect in excluding the lysosomal marker LAMP-1
but not in acquiring the reticulum endoplasmic marker calnexin, indicating that the gene participates in the early stages of the
intracellular trafficking but not in the establishment of the replicative niche. Analysis of the assembly status and functionality of
the VirB secretion apparatus indicated that the mutant has affected the proper function of this central virulence factor.
Pathogens adapted to an intracellular lifestyle have evolved so-phisticated strategies to avoid or subvert the microbicidal ac-
tivities of the host cells. These strategies are very diverse and in-
volve a wide repertoire of virulence factors involved in the
secretion and translocation, into the host cell, of proteins that
highjack the cellular machinery in its own benefit. In many cases,
the pathogen resides and multiplies in membrane-contained
niches that avoid fusionwith lysosomes. This is the case ofBrucella
spp., Gram-negative bacteria that belong to the alphaproteobac-
teria group and cause brucellosis, one of the most worldwide-
spread zoonoses that affects livestock and humans (1, 2). Brucella
is endemic in many developing countries, generating significant
economic losses due to reproductive burden and, because of its
zoonotic nature, important human health problems in areas with
high incidence. The virulence of the bacterium is dependent on its
ability to invade professional and nonprofessional phagocytes,
avoid the fusion of the vacuole that contains it with the lysosomes,
and redirect its traffic in order to generate a replicative niche with
endoplasmic reticulum-derived membranes where it will expo-
nentially multiply (3). Many of these activities are completely de-
pendent on the virB system, a type IV secretion system that se-
cretes and translocates into the host cell effector proteins that
reprogram the fate of the Brucella-containing vacuole (BCV) and
allow the establishment of the replicative niche (4). To date, only
a few effector proteins of this secretion system have been identi-
fied, and the molecular mechanisms underlying their activities
have not been elucidated yet (5–7). Although most of the work
performed so far in understanding how this bacterium survives
intracellularly has focused on the virB system, it does not mean
that this is the only virulence factor that participates in this stage of
the life cycle, as the existence of translocated proteins in a virB-
independent manner has been described (7), thus suggesting that
other secretion systems might be participating in the intracellular
life cycle.
Secretion in Gram-negative bacteria is a high-energy-consum-
ing process, as it implicates the passage of the proteins through the
inner membrane, the periplasm, the peptidoglycan, and the outer
membrane. Because of this, bacteria have evolved a wide range of
secretion systems that operate with diverse mechanisms depend-
ing on the final localization of the secreted protein (8–11). In
many cases, when the protein is secreted to the extracellular space,
translocated into the host cell, or anchored in the outer mem-
brane, it must transit through the peptidoglycan, a polymer of
sugars and amino acids that form a mesh-like layer outside the
plasma membrane. The peptidoglycan is composed of linear
chains of N-acetylglucosamine and N-acetylmuramic acid (Mur-
NAc), and the alternating sugars are connected by -1,4-glyco-
sidic bonds. Each MurNAc is attached to a short (4- to 5-residue)
amino acid chain containing, in the majority of Gram-negative
organisms, D-alanine and D-glutamic acid (12). Due to its struc-
ture, the peptidoglycan imposes an important physical barrier for
the assembly of macromolecular complexes that connect the cy-
toplasm with the outer space or for the trans-envelope transport
of proteins or DNA. For this reason, all bacteria encode murami-
dases that degrade the peptidoglycan in order to allow, for exam-
ple, the assembly of type III or type IV secretion systems essential
in virulence, motility, or conjugation (12). Muramidases are spe-
cialized enzymes of the lysozyme superfamily that generate, lo-
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cally, gaps in the peptidoglycan meshwork necessary for the as-
sembly of these macromolecular systems.
In the present work, we analyzed the function of a gene in
Brucella abortus with homology to muramidases of the lysozyme
family.We show that this gene encodes an active peptidoglycanase
and that the canonical catalytic active site is conserved. We dem-
onstrate that this gene plays an important role in the early stages of
intracellular replication in professional and nonprofessional
phagocytes but is not required for attachment or invasion. More-
over, we show that the mutant is less effective in excluding the
lysosomal marker LAMP-1 from the phagosomes but not in the
late stages of the intracellular replication process and that this
defect is, most probably, the consequence of an altered assembly
and lack of proper function of the VirB secretion system.
MATERIALS AND METHODS
Media and culture conditions. Brucella strains were grown at 37°C in
tryptic soy broth (TSB).E. coli strains were grown at 37°C in Luria-Bertani
broth. If necessary, media were supplemented with the appropriate anti-
biotics at the indicated final concentrations: ampicillin, 100 g/ml; kana-
mycin, 50 g/ml; and nalidixic acid, 5 g/ml.
Growth assay. Brucella growth curves were done in tryptic soy broth
supplemented with 5 g/ml of nalidixic acid. Overnight cultures were
diluted to an optical density at 600 nm (OD600) of 0.1 and grown at 37°C.
At the indicated time, aliquots were taken, and theOD600was determined.
RecombinantDNA techniques. (i) Constructionof plasmidpDK51/
sagA. A DNA fragment of 1,420 bp containing the sagA gene was ampli-
fied from B. abortus genomic DNA using primers CC8 (5=-CGCGGATC
CTTCGCATCCCAAGTTTCGTCCAC-3=) and CC11 (5=-CCCAAGCTT
CGCTTTCCCGAATGCATTATG-3=). This fragment was digested with
BamHI and HindIII and ligated to pDK51 plasmid (13) digested with the
same enzymes.
Construction of plasmid pDK51/sagA-tr. In order to clone the sagA
genewithout the sequence encoding the transmembrane region (sagA-tr),
a DNA fragment of 990 bp was amplified from B. abortus genomic DNA
using primers CC8 and MDG14 (5=-CCC AAGCTT CGCCCATTGCAT
CGGGCCG-3=). The resulting fragment was digested with BamHI and
HindIII and ligated into pDK51 plasmid digested with the same enzymes.
Site-directedmutagenesis and construction of expressionplasmids.
Mutagenesis of the sagA gene was carried out by the PCR-based site-
directed mutagenesis. Two point mutations were constructed: E17A
(GAA¡GCA) andD26A (GAC¡GCC). The PCRswere carried out using
as the template the pDK51/sagA-tr plasmid with two pairs of mutagenic
primers: MDG08 (5=-TGTCTTCTCGGATGCAGGCGGGTATGTC-3=)
and MDG09 (5=-CGACATACCCGCCTGCATCCGAGAAGACA-3=) for
the GAA¡GCA mutation and MDG10 (5=-CGATCATCCGAAAGCCC
CCGGCGGCGCAAC-3=) and MDG11 (5=-GTTGCGCCGCCGGGGGC
TTTCGGATGATCG-3=) for the GAC¡GCC mutation. Both mutations
were confirmed by DNA sequencing.
Using primersMDG16 (5=-CGCGGATCCGCCGAAAGGAAATCAC
CAATGG-3=) and MDG14 (5=-CCC AAGCTT CGCCCATTGCATCGG
GCCG-3=), the sagA-tr wild type and point mutants were amplified from
the corresponding pDK51/sagA plasmids. The PCR products were di-
gested with BamHI and HindIII and ligated to the expression vector
pQE30 (Qiagen; the QIAexpress system) digested with the same enzymes.
Construction of sagA, sagB, and sagA sagB mutant strains.
To construct a B. abortus 2308 sagAmutant strain, the regions flanking
the sagA gene were amplified and ligated using the recombinant PCR
technique (14). The resulting fragment was digested with BamHI and
HindIII and ligated to the pK18mobSacB plasmid digested with the same
enzymes. The primers used for PCR amplification were CC8 (5=-CGCGG
ATCCTTCGCATCCCAAGTTTCGTCCAC-3=) and CC9 (5=-ATTCGTT
GCGCCGCCGGGGTCTTT-3=) to amplify a 300-bpupstream region and
CC10 (5=-GGCGGCGCAACGAATTCTGGGCTCTCATCCCAAACT-
3=) and CC11 (5=-CCC AAGCTTCGCTTTCCCGAATGCATTATG-3=)
to amplify a 400-bp downstream region; CC8 and CC11 were used in
overlapping PCR.
To construct a B. abortus 2308sagBmutant strain, the regions flank-
ing the sagB gene were amplified and ligated using the recombinant PCR
technique (14). The resulting fragment was digested with BamHI and PstI
and ligated to the pK18mobSacBplasmid digestedwith the same enzymes.
The primers used for PCR amplification were MDG1 (5=-CGCGGATCC
AAGGAAGTTCGGCTCCACCTC-3=) and MDG2 (5=-AATTTGCCCCT
ACTTTAGATTTTG-3=) to amplify a 500-bp upstream region andMDG3
(5=-AAGTAGGGGCAAATTATAACTCTCTTTTGAAAACAT-3=) and
MDG4 (5=-CCC AACTGCAGAACCGCCGTATTACGCGATCAGCC-
3=) to amplify a 500-bp downstream region;MDG1 andMDG4were used
in the overlapping PCR.
In both cases, the resulting plasmids were introduced into B. abortus
2308 by biparental mating using the Escherichia coli S17-pir strain. Dou-
ble recombination events (Kms Sacr)were selected, and the gene knockout
was confirmed by genomic PCR.
To construct thesagAsagB doublemutant strain, the sagB genewas
deleted in the sagAmutant.
Construction of complemented strains. Plasmids pDK51 containing
sagA wild-type and mutant genes were introduced into B. abortus 2308
and sagA strains by biparental mating.
Construction of sagA-3Flag and bpe123-3Flag merodiploid
strains. To construct a B. abortus 2308 sagA merodiploid strain, the 3
Flag-tagged sagA gene was amplified from the pBBR1-MCS4/sagA-
3Flag plasmid using the primers CC7-Flag (CGCGGATCCACT CTAG
AGATCGTCATCCTTGTAA) and MDG16. The resulting fragment was
digested with BamHI and ligated to the pK18mobSacB plasmid digested
with the same enzyme. The resulting plasmidwas introduced intoB. abor-
tus 2308 by biparental mating using the E. coli S17-pir strain. Simple
recombination events (Kmr Sacs) were selected, and the presence of the
integrated plasmid was confirmed by genomic PCR.
B. abortus 2308 and sagA bpe123-3Flag merodiploid strains were
constructed as indicated for sagAmerodiploid construction and by using
the plasmid described in reference 7.
Protein expression and purification. The recombinant poly-histi-
dine-tagged SagA wild type or mutants were expressed in E. coli and pu-
rified using nickel affinity chromatography under native conditions.
Briefly, E. coli was grown at 37°C at 250 rpm, and the expression was
induced with IPTG (isopropyl--D-thiogalactopyranoside) at an OD600
of 0.6. Three hours postinduction, cells were harvested and lysed by son-
ication. Supernatants were recovered and applied to a HisTrap HP col-
umn (GE Healthcare). The protein was eluted with 200 mM imidazole.
For the peptidoglycanase assays, imidazole was eliminated by dialysis.
Peptidoglycanase activity assay. Peptidoglycanase activity was deter-
mined according to the turbidimetric method (15), based on the decrease
in turbidity of aMicrococcus lysodeikticus cell suspension in 50mMpotas-
sium phosphate buffer (pH 6.2). Briefly, 20 g of purified recombinant
SagA was added to 1.9 ml of lyophilized M. lysodeikticus (Sigma) cell
suspension (OD450 0.75 to 0.8). The decrease in absorbance at 450 nm
was monitored during 2 min using a Beckman DU650 spectrophotome-
ter. Each assay was the result of triplicate measurements. The activity was
expressed as the rate of decrease in absorbance per minute.
Intracellular replication assays. A standard antibiotic protection as-
say was performed in human epithelial cell line HeLa and murine macro-
phage-like J774 A.1 cells (16). Cells were seeded in 24-well plates in suit-
able culture medium at 105 cells per ml and incubated overnight at 37°C.
Brucella strains were grown in TSB with the appropriate antibiotics for 24
h and diluted in culture medium prior to infection. The suspension was
added at the indicatedmultiplicity of infection (50:1 for J774 A.1 cells and
500:1 for HeLa cells) and centrifuged at 300 g for 10 min. After 30 min
or 1 h (depending on the assay) of incubation at 37°C, cells were washed
and fresh medium containing 100 g per ml of streptomycin and 50 g
per ml of gentamicin was added. At 1, 2, 4, 24, or 48 h postinfection
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(depending on the assay), cells were washed and lysed with 0.1% Triton
X-100. The intracellular number of CFUwas determined by direct plating
on TSB agar plates.
Immunofluorescence microscopy. Cells were seeded on glass cover-
slips and infected as described above. At different times postinfection,
cells were washed three times with phosphate-buffered saline (PBS) and
fixed for 15 min in 4% paraformaldehyde and then processed for immu-
nofluorescence labeling. Briefly, coverslips were washed three times with
PBS and incubated for 15 min with PBS added with 50 mM NH4Cl in
order to quench free aldehyde groups. Coverslips were then incubated
with the primary antibodies in a PBS-10% horse serum-5% bovine serum
albumin-0.1% saponin solution for 1 h at room temperature, washed in
PBS, and then incubated with the secondary antibodies in a PBS-10%
horse serum-5%bovine serum albumin-0.1% saponin solution under the
same conditions. The coverslips were mounted onto glass slides using
FluorSave reagent (Calbiochem). Cells were observed in an immunoflu-
orescence microscope (Nikon-Eclipse T2000) using a 100 oil immer-
sion objective. Projections were saved in TIFF format and imported to
Adobe Photoshop CS, where images were merged using RGB format. To
determine the percentages of bacteria that colocalized with the lysosomal
marker LAMP-1, a minimum of 100 intracellular bacteria (visualized by
indirect immunofluorescence) were counted. The assays were performed
in triplicate. The primary antibodies used were mouse anti-human
LAMP-1H4A3 (Developmental StudiesHybridomaBank,Department of
Biological Sciences, University of Iowa; dilution, 1:200), rabbit anti-hu-
man calnexin (Sigma; dilution, 1:1,000), rabbit anti-Brucella polyclonal
antibody (dilution, 1:1,500), andmouse anti-O-polysaccharidemonoclo-
nal antibody (M84; dilution, 1:1,000) (17).
The secondary antibodies used were goat anti-mouse or goat anti-
rabbit Alexa Fluor 568 or 488 antibodies (Molecular Probes, Invitrogen
Co.) at a 1:4,000 dilution. For DNA staining, DAPI (4=,6-diamidino-2-
phenylindole) dye at 0.5 mg/ml (final concentration) was used.
Adherence and internalization assays. To determine adhesion and
invasion, infected HeLa cells were fixed for 15 min in 4% paraformalde-
hyde (pH 7.4) at room temperature at 4 h postinfection. Coverslips were
washed three times with PBS, incubated for 10 min with PBS added with
50mMNH4Cl, and, before permeabilization, incubated with the primary
antibody rabbit anti-Brucella polyclonal antibody (dilution 1:1,500) in a
PBS-10% horse serum solution. Then cells were washed and incubated
with the other primary antibody mouse anti-M84 (anti-O-antigen)
monoclonal antibody (dilution, 1:1,000) in a PBS-10%horse serum-0.1%
saponin solution followed by incubation with the secondary antibodies
(Alexa Fluor 568 or 488;Molecular Probes, Invitrogen Co.) in a PBS-10%
horse serum-0.1% saponin solution. The coverslips were mounted as de-
scribed before. Invasion was determined as the number of bacteria posi-
tive for both labels versus the ones positive for the anti-mouse antibody
labeling. Adhesion was determined counting the number of bacteria as-
sociated per 100 HeLa cells.
Western blot analysis. (i) Outer membrane protein analysis. Cells
were harvested at 8,000  g, resuspended in buffer A (15 mM Tris-HCl
[pH 8], 0.45mM sucrose, 8mMEDTA [pH 8], 0.4mg/ml) and incubated
for 15 min at 4°C. Then, cells were centrifuged (8,000  g, 15 min) and
sonicated in buffer B (50 mM Tris-HCl [pH 7.6], 5 mM MgCl2, 2 mM
phenylmethylsulfonyl fluoride [PMSF], deoxyribonuclease I [DNAse]).
The sonicated cells were centrifuged, and supernatant was recovered. In-
soluble membrane fractions were recovered by ultracentrifugation and
homogenized in 50 mM Tris-HCl, pH 7.6.
Brucella membrane extracts were submitted to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE; 10%) and transferred to ni-
trocellulose membranes. The presence of outer membrane proteins (OMPs)
was assessed by immunoblot analysis with monoclonal antibodies (dilution,
1:2,000) specific for OMPs 10, 16, 19, and 25 (18, 19).
(ii) VirB proteins. Brucella whole-cell extracts and cell membranes
were resuspended in Laemmli sample buffer and heated to 100°C for 5
min. For cell membranes, nonreducing conditions were preserved. Sam-
ples were submitted to SDS-PAGE (12.5%) and transferred to nitrocellu-
lose membranes. The presence of VirB5 and VirB8 proteins was carried
out by immunoblot analysis using rabbit polyclonal antibodies specific for
VirB5 andVirB8 (dilution, 1:2,000) (20) and IRDye secondary anti-rabbit
antibody (LI-COR, Inc.). Detection was performed using the Odyssey
Imaging System (LI-COR, Inc.).
Secretion of Bpe123. J774 A.1 cells were infected with the bpe123
merodiploid strains expressing bpe123-3Flag (multiplicity of infection
[MOI], 50:1). At 4 h postinfection, cells were washed three times with PBS
and fixed for 15 min in 4% paraformaldehyde and then processed for
immunofluorescence labeling using rabbit anti-Brucella polyclonal anti-
body (dilution, 1:1,500) and anti-Flag monoclonal antibody (dilution,
1:4,000). The secondary antibodies used were goat anti-mouse Alexa
Fluor 488 and goat anti-rabbit Alexa Fluor 568 (Molecular Probes, Invit-
rogenCo.) at a 1:4,000 dilution. ForDNA staining, DAPI dye at 0.5mg/ml
(final concentration) was used. Colocalization was determined by count-
ing the number of bacteria positive for both labels and expressed as per-
centages of Flag-positive BCVs.
In vitro susceptibility to low pH. PBS was adjusted to pH 3.5, 4, 5, or
7 by adding 1 N HCl. PBS solutions with different pHs were inoculated
with 1  107 CFU/ml of wild-type or mutant strains and incubated at
37°C for 1 h, after which serial dilutions of each culture were plated on
TSB agar to determine viable bacteria.
RESULTS
Bab1_1002 of Brucella abortus encodes an active muramidase.
With the purpose of identifying novel virulence factors in B. abor-
tus, we performed a bioinformatic search seeking for potential
horizontally transmitted regions. For this, we identified trans-
posases or recombinases close to transfer RNAs and analyzed the
genes present in those regions to determine homology to known
virulence factors or eukaryotic proteins. Using this approach, we
identified several potentially horizontally transmitted regions,
among which was a previously identified pathogenicity island
named genomic island II (21) and an island coding for a novel
adhesin (14). The genomic island II is absent in the nonpatho-
genic species Brucella ovis and encodes 20 genes, many of which
have no function assigned. One of these genes is Bab1_1002,
which encodes a potential membrane-bound 252-amino-acid
protein with homology to lysozymes, enzymes that degrade the
peptidoglycan. A more detailed examination of this homology
revealed that this gene is similar to proteins identified as secretion
activators, as they stimulate the secretion of levansucrase and in-
vertase inZymomonasmobilis (22) and participate in the secretion
of the typhoid toxin (23) in Salmonella enterica serovar Typhi (J. E.
Ugalde, S. Spano, and J. E. Galán, unpublished data) (Fig. 1A). For
these reasons, we renamed Bab1_1002 sagA, for secretion activa-
tor gene A.
To determine if the protein product of sagA has muramidase
activity, we determined the enzymatic activity of a recombinant
protein lacking the transmembrane region (amino acids 223 to
245) by measuring the decrease in absorbance at 480 nm of a
Micrococcus lysodeikticus suspension, a substrate of lysozymes. As
negative controls, we included the recombinant proteins with
point mutations in two residues involved in the catalytic activity
(Fig. 1A). As can be observed in Fig. 1B and C, recombinant SagA
showed muramidase activity that was completely abolished when
amino acid glutamic 17 was replaced by alanine and significantly
reduced when the amino acid aspartic 26 was replaced by alanine.
These results indicate that sagA codes for an active muramidase.
SagA is required for the early stages of intracellular replica-
tion. To determine if sagA plays a role in the pathogenicity of B.
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abortus, a deletion mutant was constructed as indicated in Mate-
rials and Methods, and the intracellular multiplication in HeLa
and J774 A.1 cells was determined in comparison to the parental
wild-type strain. Figure 2A and B show that deletion of sagA re-
sulted in a significant reduction (over 10-fold) in the intracellular
bacterial load at 4 h postinfection in both HeLa and J774 A.1 cells.
Despite this early-stage reduction in the intracellular bacterial
load, the mutant was able to replicate with similar kinetics to that
of the wild-type parental strain, indicating that the defect was
restricted to the initial phases of the infection. To determine if this
difference was dependent on the multiplicity of infection (MOI),
an antibiotic protection assay was performed with dilutions of
1:50, 1:100, and 1:500 in HeLa cells, and the intracellular bacterial
load was determined at 4 h postinfection. As shown in Fig. 2C, at
all testedMOI, themutant displayed a significant reduction in the
intracellular survival. This phenotype was not the result of a gen-
eral growth deficiency, as the growth curve of the mutant was
undistinguishable from that of the parental wild-type strain (Fig.
2D). Moreover, the mutant did not show any defects in the mem-
brane expression of several major outer membrane proteins (Fig.
2E), indicating that the mutation did not result in a generalized
outer membrane alteration.
The reduction in bacterial survival at 4 h postinfection could be
the consequence of a reduced attachment capacity, less invasive-
ness, or a defect in the ability to resist the initial bactericidal attack
of the cell. To distinguish between these possibilities, we first eval-
uated the attachment and the invasion capacity of the mutant
strain determining the number of cell-associated bacteria (attach-
ment) and the percentage of internalized bacteria by an in-out
differential staining (invasion) (14). As can be observed in Fig. 3A,
the sagA strain showed no significant differences in the attach-
ment or in the invasion of HeLa cells compared to those of the
wild-type strain. These results prompted us evaluate if the differ-
ences observed in the intracellular viable counts were the conse-
quence of an increased degradation or inactivation of the mutant.
For this, we determined the number of LAMP-1-positive BCVs at
4 and 24 h postinfection in HeLa cells for the sagA mutant and
the parental wild-type strains. As shown in Fig. 3B, the mutant
showed a reduced capacity to exclude the lysosomal marker
LAMP-1 at 24 h postinfection in comparison with the wild-type
strain, indicating that the absence of sagA decreases the ability of
the bacteria to avoid the fusion of the BCV with lysosomes. Albeit
this, the bacteria that were able to avoid its degradation replicated
in a compartment calnexin positive as the wild-type strain (Fig.
3D). All together, these results indicate that sagA is required dur-
ing the initial phases of the intracellular life cycle participating in
the process in which the BCV avoids maturation into an active
lysosome. To determine if this early intracellular deficiency was
the consequence of an increased acid sensitivity of the mutant, we
performed an acid resistance assay as described in Materials and
Methods. The results shown in Fig. S1 in the supplemental mate-
rial indicate that the mutant did not display any increased sensi-
tivity to low pH.
To determine if the peptidoglycanase activity of SagA is re-
quired in the early stages of the intracellular life cycle, the sagA
mutant was complemented with a plasmid coding for a version of
the gene with the point mutation E17A, and the intracellular rep-
lication capacity was evaluated in HeLa cells. As shown in Fig. 4,
complementation with this mutant did not restore the wild-type
levels of intracellular CFU at 4 h postinfection, indicating that the
peptidoglycanase activity is required for the activity of sagAduring
the infectious process.
To determine if the early intracellular survival defect at 4 h
postinfection was also observed at earlier time points, we per-
formed an intracellular survival assay in J774 A.1 cells and deter-
mined the bacterial loads at 1 and 2 h postinfection. We also in-
FIG 1 SagA is an active muramidase. (A) Protein alignment of SagA of Brucella abortus with enzymes from the bacteriophage T4, Zymomonas mobilis and
Salmonella enterica. In gray are highlighted two conserved catalytic amino acids. (B) Enzymatic activity determinedwith different concentrations of recombinant
SagA or the enzymewith the pointmutations E17A andD26A. Activity determined at 10min of reaction. (C) Activity of the site-directedmutants. *, P 0.0001;
**, P 0.05.
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cluded in this assay theB. abortus virB10mutant (24). As shown in
Fig. S2 in the supplementalmaterial, themutant displayed a defect
at very early time points postinfection, indicative that the gene
plays a role in the initial biogenesis of the BCV. Surprisingly, the
virB mutant also displayed a similar intracellular defect at these
very early time points, even though it has been revealed that until
4 h postinfection, a virB9mutant had no phenotype in bone mar-
row-derived macrophages (25).
SagA participates in the assembly and proper function of the
VirB secretion system. The defect in the early stages of the intra-
cellular replication process observed with the mutant and also
with the virB10 mutant suggested that one of the systems poten-
tially affected in this strain could be the VirB secretion apparatus.
To test this, we analyzed the assembly status of two proteins of the
system in themembrane of the bacteria (VirB5 andVirB8) and the
functionality of the translocation apparatus determining the se-
cretion of a known substrate, the product of Bab2_0123 (7). As
can be observed in Fig. 5A, while both proteins were expressed at
similar levels in thewild-type andmutant strains (whole bacteria),
when total membranes submitted to SDS-PAGE without the ad-
dition of a reducing agent were used, the wild-type and mutant
strains showed different band patterns for both VirB5 and VirB8
proteins. More specifically, while in the wild-type parental strain
both proteins showed a band corresponding to the monomer and
a higher band most probably due to an association with another
protein of the complex, the mutant strain exhibited only the
monomer form in VirB8 and a significantly less abundant com-
plex band in the case of VirB5. As a control for a membrane pro-
tein, an OMP19 Western blot was included. This result demon-
strates that, even thoughwe are not able to explain the associations
of these proteins observed in the wild-type strain because, to date,
there is no thorough physical map of the VirB system in Brucella,
whatever VirB5 and VirB8 complexes are formed in the mem-
brane of the bacteria, these are not present in the mutant, indicat-
ing that the VirB complex is altered. Because an altered assembly
of the VirB system does not imply a defect in the secretion, we
analyzed functionality determining, at 4 h postinfection, the se-
cretion of an effector protein (Bpe123) recently identified as a type
FIG 2 sagA is involved in the early stages of the intracellular replication process. (A) Intracellular replication in HeLa cells; (B) intracellular replication in J774
A1 cells; (C) intracellular CFU 4 h postinfection determined with different multiplicity of infection (MOI) in HeLa cells; (D) growth curve of the wild type and
the sagA deletion strain in TSB; (E) abundance of OMPs 10, 16, 19, and 25 in the membranes of wild-type and sagA strains.
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IV substrate in B. abortus (7). To do this, we constructed two
merodiploid strains carrying a chromosomal 3Flag of Bpe123 in
the wild-type and sagAmutant strains and analyzed, with them,
secretion of the protein during the infection of J774 A.1 cells by
immunofluorescence with a monoclonal anti-3 Flag antibody.
As can be observed in Fig. 5B, C, and D, the mutant strain showed
significantly less surface-exposed Bpe123 than the wild-type
strain, even though both strains expressed the protein at similar
levels. All together, these results demonstrate that SagA is involved
in the assembly of a functional VirB system and suggest that the
phenotype observed during the early stages of the intracellular
replication stage is probably the consequence of this defective as-
sembly.
sagB, a homologue of sagA, also participates in the early
stages of intracellular replication.Analysis of the chromosomeof
B. abortus 2308 revealed the presence of an open reading frame
with high similarity to sagA, Bab1_0875 (Fig. 6A), that we named
sagB. The protein encoded by this gene, with a 54% identity and a
72% similarity to SagA, has the conserved catalytic residues and a
FIG3 sagA is involved in the early stages of the intracellular trafficking of the BCV. (A)Adherence and internalization of thewild-type 2308 and thesagA strains
to HeLa cells at 4 h postinfection. The percentage of internalized bacteria and the number of bacteria adhered per 100 HeLa cells were calculated as indicated in
Materials and Methods. (B) Determination of LAMP-1-positive BCVs at 4 and 24 h postinfection of the wild-type and the sagA mutant in HeLa cells. (C)
Representative images of the LAMP-1-positive and -negative BCVs. *, P 0.05. (D) Representative image of calnexin-positive BCVs of thesagAmutant at 48 h
postinfection.
FIG 4 The muramidase activity of sagA is required for the early stages of the
intracellular replication process. Intracellular replication curve in HeLa cells
with the sagA strain complemented with the wild type and the site-directed
E17A mutant.
Muramidase in Brucella abortus
March 2013 Volume 81 Number 3 iai.asm.org 961
 o
n
 Septem
ber 8, 2017 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
transmembrane domain in the carboxy terminus. To determine if
this gene plays a role similar to the one of sagA, we generated a
deletion mutant strain and a double mutant (see Materials and
Methods) and analyzed the intracellular replication capacity in
HeLa cells. As can be observed in Fig. 6B, deletion of sagB resulted
in a strain with a phenotype similar to that of the sagA strain,
with reduced bacterial load at 4 h postinfection but with the ca-
pacity to replicate with kinetics similar to the wild type. Interest-
ingly, the double mutant did not show an enhanced defect but
had, at 4 h postinfection, a bacterial load similar to the single
mutant. One interesting observation was that complementation
of thesagBmutant with plasmid pDK51/sagA-tr coding for sagA
did not complement the phenotype (not shown). This strongly
suggests that, even though there is a high conservation between
genes, they donot play redundant roles, a hypothesis supported by
the fact that each single mutant per se has a phenotype.
DISCUSSION
Secretion of proteins is central for the virulence of all pathogenic
bacteria known to date and, in the case of Gram-negative organ-
isms, this process requires the translocation of the cognate pro-
teins across the peptidoglycan. To achieve this, the proteins must
cross this mesh-like polymer for which there are specialized en-
zymes that degrade it in a precise temporal and spatial organiza-
tion. These proteins belong to the family of the lysozyme-like en-
zymes that are widely distributed in bacteria (26) and have the
capacity to cleave the -1,4 glycosidic bond between theMurNAc
and GlcNAc in the peptidoglycan. Even though there are several
genes with homology to lysozyme-like enzymes in the Brucella
genomes, none have been characterized to date. We report here
the identification and characterization of a lysozyme-like enzyme
of Brucella abortus, which we have named SagA.We have demon-
strated that this protein has peptidoglycanase activity that is de-
pendent on conserved catalytic amino acids of this family of en-
zymes. The deletion of sagA rendered a strain with a significant
defect in the early stages of the intracellular cycle in professional
and nonprofessional phagocytes determined by standard intracel-
lular multiplication assays. Moreover, this defect is the conse-
quence of the absence of the enzymatic activity, because an inac-
tive protein was unable to complement the mutant. Even though
the mutant showed a significant decrease in the viable counts at 4
h postinfection, the strain was able to replicate with kinetics sim-
ilar to that of the wild type, indicating that the defects were in the
attachment, invasion, or early intracellular trafficking. Our results
indicate that neither the attachment nor the invasion was affected
but rather the capacity to avoid the fusion of the BCV with the
lysosomes as evidenced by a defect in excluding the lysosomal
marker LAMP-1, indicating that the gene plays a role in modulat-
ing the intracellular trafficking. To explore if this early intracellu-
lar trafficking defect was the consequence of an altered VirB sys-
tem, we analyzed the assembly status and functionality of the
complex, determining the migratory properties of two proteins of
the macromolecular complex in the bacterial membrane and the
secretion of a known substrate of the system. Our results indicate
that SagA participates in the assembly of the VirB system and that
the defective early intracellular survival is probably the conse-
quence of this defect. It is important to highlight the fact that the
first gene in the virB operon (virB1) encodes a lysozyme-like en-
zyme, and it has been shown to be important for the intracellular
replication but not in the animal model (27). The fact that the
virB1 mutant is still able to replicate in cells but with difficulties
indicates that the trans-glycosidase activity is redundant, a hy-
FIG 5 sagA is involved in the assembly of a functional VirB secretion system. (A) Western blot analysis of VirB5 and VirB8 components of the VirB macromo-
lecular complex in whole bacteria and membranes of the wild-type and sagA mutant strains. Total membranes of the wild-type and mutant strains were
subjected to SDS-PAGE in the absence of any reducing agent and probed with rabbit anti-VirB5 and -VirB8 antibodies. (B) Percent of bacteria positive for
surface-exposed Bpe123 in J774A.1-infected cells with themerodiploid strains (wild type andsagA) carrying a copy of the gene fused to a 3 Flag tag. Cells were
infected for 4 h, fixed, and stained with amonoclonal anti-Flag and a rabbit polyclonal anti-Brucella antibody. The inset shows the expression levels of the tagged
Bpe123 in both strains. **, P 0.005. (C and D) Representative pictures of the quantification shown in panel B.
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pothesis strengthened by our results that indicate that sagA also
plays a role in the assembly of the VirB complex.
Examination of the genome of B. abortus resulted in the iden-
tification of a gene, sagB, highly similar to sagA. A deletionmutant
in this gene also resulted in a strain with a defect in the early stages
of the intracellular replication process, but sagAwas not capable of
cross-complementation, indicating, a priori, that they do not have
redundant functions. Because bacteria have several macromolec-
ular membrane complexes devoted to virulence, it could be pos-
sible that sagA and sagB play a similar function in the assembly
of different secretion complexes involved in the intracellular
life cycle.
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